Structural and mechanistic basis of neutralization by a pan-hantavirus protective antibody.
Eva MittlerAlexandra SerrisEmma S EstermanCatalina FlorezLaura C PolancoCecilia M O'BrienMegan M SloughJanne TynellRemigius GröningYan SunDafna M AbelsonAnna Z WecDenise HaslwanterMarkus KellerChunyan YeRussel R BakkenRohit K JangraJohn M DyeClas AhlmC Garrett RappazzoRainer Günter UlrichLarry ZeitlinJames C GeogheganSteven B BradfuteSimone SidoliMattias N E ForsellTomas M StrandinFelix A ReyAndrew S HerbertLaura M WalkerKartik ChandranGuardado-Calvo PabloPublished in: Science translational medicine (2023)
Emerging rodent-borne hantaviruses cause severe diseases in humans with no approved vaccines or therapeutics. We recently isolated a monoclonal broadly neutralizing antibody (nAb) from a Puumala virus-experienced human donor. Here, we report its structure bound to its target, the Gn/Gc glycoprotein heterodimer comprising the viral fusion complex. The structure explains the broad activity of the nAb: It recognizes conserved Gc fusion loop sequences and the main chain of variable Gn sequences, thereby straddling the Gn/Gc heterodimer and locking it in its prefusion conformation. We show that the nAb's accelerated dissociation from the divergent Andes virus Gn/Gc at endosomal acidic pH limits its potency against this highly lethal virus and correct this liability by engineering an optimized variant that sets a benchmark as a candidate pan-hantavirus therapeutic.
Keyphrases
- advanced non small cell lung cancer
- gas chromatography
- endothelial cells
- transcription factor
- sars cov
- ionic liquid
- small molecule
- early onset
- disease virus
- epidermal growth factor receptor
- multiple myeloma
- tandem mass spectrometry
- mass spectrometry
- induced pluripotent stem cells
- high resolution
- tyrosine kinase
- molecular dynamics simulations
- liquid chromatography